Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $13.32 million. The enterprise value is -$15.39 million.
| Market Cap | 13.32M |
| Enterprise Value | -15.39M |
Important Dates
The last earnings date was Friday, August 14, 2026, after market close.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 2.14 million shares outstanding. The number of shares has increased by 579.35% in one year.
| Current Share Class | 2.14M |
| Shares Outstanding | 2.14M |
| Shares Change (YoY) | +579.35% |
| Shares Change (QoQ) | +237.33% |
| Owned by Insiders (%) | 6.59% |
| Owned by Institutions (%) | 6.37% |
| Float | 1.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 85.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.63
| Current Ratio | 5.63 |
| Quick Ratio | 5.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.57 |
Financial Efficiency
Return on equity (ROE) is -2,011.66% and return on invested capital (ROIC) is -250.31%.
| Return on Equity (ROE) | -2,011.66% |
| Return on Assets (ROA) | -40.08% |
| Return on Invested Capital (ROIC) | -250.31% |
| Return on Capital Employed (ROCE) | -48.01% |
| Weighted Average Cost of Capital (WACC) | 11.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$11.56M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.17% in the last 52 weeks. The beta is 1.29, so ADIL's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -33.17% |
| 50-Day Moving Average | 3.35 |
| 200-Day Moving Average | 3.82 |
| Relative Strength Index (RSI) | 79.07 |
| Average Volume (20 Days) | 83,728 |
Short Selling Information
The latest short interest is 233,654, so 10.90% of the outstanding shares have been sold short.
| Short Interest | 233,654 |
| Short Previous Month | 243,624 |
| Short % of Shares Out | 10.90% |
| Short % of Float | 17.44% |
| Short Ratio (days to cover) | 5.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.51M |
| Pretax Income | -57.80M |
| Net Income | -57.80M |
| EBITDA | -11.51M |
| EBIT | -11.51M |
| Earnings Per Share (EPS) | -$28.91 |
Balance Sheet
The company has $28.71 million in cash and no debt, with a net cash position of $28.71 million or $13.39 per share.
| Cash & Cash Equivalents | 28.71M |
| Total Debt | n/a |
| Net Cash | 28.71M |
| Net Cash Per Share | $13.39 |
| Equity (Book Value) | 156,000 |
| Book Value Per Share | -14.61 |
| Working Capital | 23.72M |
Cash Flow
| Operating Cash Flow | -11.13M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 565 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.13M |
| FCF Per Share | -$5.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -579.35% |
| Shareholder Yield | -579.35% |
| Earnings Yield | -433.86% |
| FCF Yield | -83.56% |
Analyst Forecast
The average price target for ADIL is $8.33, which is 34.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.33 |
| Price Target Difference | 34.03% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 6, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Feb 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |